I am the District People's Congress
Release time:
2020-08-14
I am a deputy to the District People's Congress
The first meeting of the Ninth People's Congress of Wucheng District, Jinhua City was held from # June 13 to 18 . I walked into the venue with representatives of the District People's Congress from all walks of life to discuss the blueprint for the development of Wucheng in the next five years. I was extremely excited.
As a grass-roots employee of Jinxi Pharmaceutical Factory of Jianfeng Pharmaceutical, I was honored to be elected as a deputy to the 9th Wucheng District People's Congress in 12 last year. In order to further improve the theoretical literacy of the deputies and enhance their ability to perform their duties, the District People's Congress organized the ninth Wucheng District People's Congress performance training meeting on July 18, 12, 19. The relevant staff of the Municipal People's Congress explained to us the superiority of the people's Congress system, the nature and responsibilities of the people's Congress and its Standing Committee, and introduced the legal status, job nature, rights and obligations of the people's Congress deputies, and how to play a representative role and perform their duties. During the period, the principal of Dongyuan Primary School, as an old representative, exchanged experience with everyone in performing their duties, and asked the deputies to the National People's Congress to enhance their awareness of representatives, firmly establish the idea of "the people elect me as a representative, and I as a representative for the people", and effectively enhance their sense of responsibility and mission. Effectively fulfill legal obligations; keep close contact with the masses, give full play to the role of deputies, actively put forward various targeted proposals, and be a qualified deputies. At the same time, in order to enable the newly elected representatives to better understand the development of Wucheng district in the first five years, the district people's congress also organized us to visit the lake seawall park, the new energy automobile town huake automobile, tangshen highway, jiufeng ranch, etc. During the 6 days of the National People's Congress, we listened to and reviewed relevant reports such as the Wucheng District Government Work Report, Economic and Social Development Plan, Wucheng District 2016 Budget, etc. Elected the Standing Committee of the Ninth People's Congress of Wucheng District, the head and deputy head of the district people's government, the director of the district supervisory committee, the president of the district people's court, and the procurator of the district people's procuratorate, and delegates to the seventh jinhua city people's congress. The meeting also announced the results of the district government's key practical vote for benefiting the people in 2017 , and determined ten practical arrangements for benefiting the people. I have participated in these agendas and have exercised my rights as a deputy to the National People's Congress together with other deputies.
I am particularly proud that Jiang Xiaomeng, chairman of the group company, and Lu Guosheng of Jianfeng Health Technology Company were elected representatives of the Seventh People's Congress of Jinhua City. This meeting also made me deeply realize that the people's representatives should always keep in mind their mission, cherish honor, earnestly perform their functions, Do not forget your initiative mind, continue to move forward, work together, forge ahead, work together to promote development, roll up their sleeves and work hard, and make new contributions to "building the core of the city and winning an all-round well-off society. (wang liqin)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page